Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could gestational diabetes cause muscle loss? new study investigates

NCT ID NCT06876090

Knowledge-focused Sponsor: Istituto di Neuroscienze Consiglio Nazionale delle Ricerche Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether women with gestational diabetes (GDM) experience muscle loss, known as sarcopenia, and how this might affect pregnancy outcomes and thinking skills. Researchers will test 200 pregnant women using muscle strength and function tests, along with standard glucose tests. The goal is to understand how common sarcopenia is in GDM and identify risk factors, which could lead to better prevention strategies in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could pave the way for future studies to prevent sarcopenia in pregnant women with gestational diabetes and reduce related complications.
What could go wrong
This is an observational study, not a treatment trial. It only measures and observes, so it won't directly improve health outcomes. Results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women, based on the inclusion and exclusion criteria as outlined above.

Ages

35 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: At least one among the following conditions: * Age equal to or higher than 35 years; * Body mass index (BMI) equal to or higher than 25 kg/m\^2; * Glycemia between 5.6 and 6.9 mmol/L before or at the beginning of pregnancy; * Fetal macrosomia in previous pregnancy; * GDM in previous pregnancy; * First-degree family history of diabetes. Exclusion Criteria: * Unmatching of at least one among the inclusion criteria; * Twin pregnancy; * Presence of any already known disease/disorder possibly affecting muscle mass or function; * Neurological or psychiatric diseases; * Already known diabetes (e.g., type 1 or type 2 diabetes).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adverse maternal and neonatal outcomes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gestational diabetes pregnancy disorder Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adverse maternal and neonatal outcomes Cognitive function Gestational diabetes mellitus (GDM) Pregnancy complications Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Clinical and Experimental Medicine, University of Pisa

    RECRUITING

    Pisa, PI, 56124, Italy

  • Department of Obstetrics and Gynaecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna

    RECRUITING

    Vienna, 1090, Austria

  • Institute of Neuroscience, National Research Council

    ACTIVE_NOT_RECRUITING

    Padova, PD, 35127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.